Onward Medical revenue quadruples to €4.2M; €40M raise boosts liquidity
Revenue and other income quadrupled year-over-year to €4.2M, driven by ARCEX commercialization and new market expansion. Net loss widened to €24.7M. A €40M capital raise and new debt facility strengthened liquidity and extended the cash runway.